Skip to main content

Regulatory and Washington

  • Reports: Obama re-nominates acting CMS administrator to lead agency

    NEW YORK — President Obama has re-nominated Marilyn Tavenner as administrator of the Centers for Medicare and Medicaid Services, according to published reports.

    The Hill, a Washington-based newspaper that covers Capitol Hill, noted that Tavenner had received an endorsement from House majority leader Eric Cantor, R-Va., who had worked with her when she was in charge of the Medicaid program in his state. Still, she could face a tougher time in the Senate.

  • FDA approves generic diabetes drug

    SILVER SPRING, Md. - The Food and Drug Administration has approved a generic diabetes drug made by Macleods Pharma, according to agency records.

    The FDA approved Macleods' pioglitazone hydrochloride tablets in the 15 mg, 30 mg and 45 mg strengths.

    The drug is a generic version of Takeda's Actos, branded and generic versions of which had sales of about $2.7 billion during the 12-month period that ended in August 2012, according to IMS Health.

  • Report: New FDA switch paradigm could bring $36 billion in prescription revenue to the front end

    MONMOUTH BEACH, N.J. — A new switch paradigm could open the door to $35.7 billion in OTC opportunity, according to a new report recently released by Francesco International. 

  • Va. pharmacy students visit state legislators

    NEW YORK — An annual event at the Virginia state General Assembly drew several students from a local pharmacy school.

    Hampton University said 24 of its students visited the General Assembly in Richmond, Va., on Jan. 30 to participate in Virginia Pharmacy Day, organized every year by the Virginia Pharmacist Association. 

    The event combined a health fair — with cholesterol, diabetes and blood pressure screenings — and legislative visits with state representatives to discuss pharmacy-related issues.

  • FDA approves multiple myeloma drug

    SILVER SPRING, Md. — The Food and Drug Administration has approved a new drug made by Celgene for treating the cancer multiple myeloma, the agency said Friday.

    The FDA announced the approval of Pomalyst (pomalidomide) for patients whose disease has progressed after treatment with other cancer drugs.

  • Survey: Part D 'preferred pharmacy' provision driving rural seniors away from community pharmacy

    ALEXANDRIA, Va. — A survey of community pharmacists suggests that "preferred pharmacy" Medicare Part D drug benefit plans may pose challenges for seniors in rural communities. The finding comes shortly after similar questions were raised at the January public meeting of the Medicare Payment Advisory Commission, Congress' advisory board on Medicare issues, the National Community Pharmacists Association noted Thursday. 

  • Vaccine-resistant whooping cough bacteria strain may have appeared in U.S., researchers say

    NEW YORK — A new strain of the bacterium that causes whooping cough immune to vaccines may have appeared in the United States, according to a brief published Thursday in the New England Journal of Medicine.

    The brief, filed by officials from the Centers for Disease Control and Prevention and other health authorities, reported that a strain of Bordetella pertussis had been reported in Japan, France and Finland and may have appeared in Philadelphia, where 12 children were hospitalized between 2011 and 2012.

  • CMS study further proof community pharmacy can improve patients' lives, says NACDS

    ARLINGTON, Va. — National Association of Chain Drug Stores (NACDS) president and CEO Steve Anderson, calls a new study by the Centers for Medicare and Medicaid Services (CMS) “further proof of community pharmacy’s ability to improve patients’ lives while making healthcare more affordable in this country.”

X
This ad will auto-close in 10 seconds